Literature DB >> 20035276

Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.

Joanne Kotsopoulos1, Heather J Baer, Shelley S Tworoger.   

Abstract

Epidemiologic evaluations of the relationship between anthropometry and ovarian cancer risk have not been conclusive. Using data collected from two large cohorts, the Nurses' Health Study (NHS) and NHSII, we prospectively evaluated the association between waist and hip circumference, the waist-to-hip ratio (WHR), and BMI with risk of epithelial ovarian cancer. Women completed biennial questionnaires assessing ovarian cancer risk factors beginning in 1976 (NHS) and 1989 (NHSII). For the WHR and BMI analyses, 333 and 862 confirmed cases were identified, respectively, through 1 June 2006 (NHS) and 1 June 2005 (NHSII). WHR and waist circumference were not associated with risk (P-trend = 0.63 and 0.65, respectively). There was evidence for a decreased risk with increasing hip circumference among postmenopausal women (P-trend = 0.03), but a suggestive positive association among premenopausal women (P-trend = 0.04) (P-interaction = 0.01). The hazard ratios (HRs) comparing the highest vs. lowest quintile of hip circumference among pre- and postmenopausal women were 1.54 (95% confidence interval (CI) = 0.45-5.23) and 0.66 (95%CI = 0.37-1.16), respectively. BMI was not clearly associated with risk in pre- or postmenopausal women. Results from this large prospective study suggest that hip circumference could be a possible risk factor for premenopausal ovarian cancer, but may reduce risk of postmenopausal ovarian cancer. The differential effect of hip circumference based on menopausal status requires further confirmation.

Entities:  

Mesh:

Year:  2009        PMID: 20035276      PMCID: PMC2888954          DOI: 10.1038/oby.2009.461

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  37 in total

Review 1.  Body size and ovarian cancer: case-control study and systematic review (Australia).

Authors:  D M Purdie; C J Bain; P M Webb; D C Whiteman; S Pirozzo; A C Green
Journal:  Cancer Causes Control       Date:  2001-11       Impact factor: 2.506

2.  Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study.

Authors:  Marieke B Snijder; Jacqueline M Dekker; Marjolein Visser; Lex M Bouter; Coen D A Stehouwer; Piet J Kostense; John S Yudkin; Robert J Heine; Giel Nijpels; Jacob C Seidell
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

3.  Circulating levels of sex steroid hormones and risk of ovarian cancer.

Authors:  Annekatrin Lukanova; Eva Lundin; Arslan Akhmedkhanov; Andrea Micheli; Sabina Rinaldi; Anne Zeleniuch-Jacquotte; Per Lenner; Paola Muti; Carine Biessy; Vittorio Krogh; Franco Berrino; Göran Hallmans; Elio Riboli; Rudolf Kaaks; Paolo Toniolo
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

4.  Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer.

Authors:  Leo J Schouten; R Alexandra Goldbohm; Piet A van den Brandt
Journal:  Am J Epidemiol       Date:  2003-03-01       Impact factor: 4.897

5.  Body size indices at different ages and epithelial ovarian cancer risk.

Authors:  L Dal Maso; S Franceschi; E Negri; E Conti; M Montella; S Vaccarella; V Canzonieri; F Parazzini; C La Vecchia
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

6.  Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women.

Authors:  Carmen Rodriguez; Eugenia E Calle; Dorna Fakhrabadi-Shokoohi; Eric J Jacobs; Michael J Thun
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-09       Impact factor: 4.254

7.  Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women.

Authors:  Anders Engeland; Steinar Tretli; Tone Bjørge
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

8.  Obesity, weight gain, and ovarian cancer.

Authors:  Kathleen M Fairfield; Walter C Willett; Bernard A Rosner; JoAnn E Manson; Frank E Speizer; Susan E Hankinson
Journal:  Obstet Gynecol       Date:  2002-08       Impact factor: 7.661

9.  Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study.

Authors:  Jeffrey P Anderson; Julie A Ross; Aaron R Folsom
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860

10.  Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.

Authors:  H J Baer; S E Hankinson; S S Tworoger
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

View more
  12 in total

1.  Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort.

Authors:  Alison J Canchola; Ellen T Chang; Leslie Bernstein; Joan A Largent; Peggy Reynolds; Dennis Deapen; Katherine D Henderson; Giske Ursin; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2010-10-06       Impact factor: 2.506

2.  Association of Ovarian Tumor β2-Adrenergic Receptor Status with Ovarian Cancer Risk Factors and Survival.

Authors:  Tianyi Huang; Shelley S Tworoger; Jonathan L Hecht; Megan S Rice; Anil K Sood; Laura D Kubzansky; Elizabeth M Poole
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-01       Impact factor: 4.254

3.  Prospective Analyses of Sedentary Behavior in Relation to Risk of Ovarian Cancer.

Authors:  Andrea L Buras; Tianyi Wang; Junmin Whiting; Mary K Townsend; Brooke L Fridley; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2022-05-20       Impact factor: 5.363

4.  Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Authors:  Jennifer Ose; Helena Schock; Anne Tjønneland; Louise Hansen; Kim Overvad; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopolou; Vassiliki Benetou; Pagona Lagiou; Giovanna Masala; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B As Bueno-de-Mesquita; Petra H M Peeters; N Charlotte Onland-Moret; Elisabete Weiderpass; Inger T Gram; Soledad Sánchez; Mireia Obon-Santacana; Maria-José Sànchez-Pérez; Nerea Larrañaga; José María Huerta Castaño; Eva Ardanaz; Jenny Brändstedt; Eva Lundin; Annika Idahl; Ruth C Travis; Kay-Tee Khaw; Sabina Rinaldi; Isabelle Romieu; Melissa A Merritt; Marc J Gunter; Elio Riboli; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-08       Impact factor: 4.254

5.  Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.

Authors: 
Journal:  PLoS Med       Date:  2012-04-03       Impact factor: 11.069

6.  Genetic Predisposition to Central Obesity and Risk of Type 2 Diabetes: Two Independent Cohort Studies.

Authors:  Tao Huang; Qibin Qi; Yan Zheng; Sylvia H Ley; JoAnn E Manson; Frank B Hu; Lu Qi
Journal:  Diabetes Care       Date:  2015-04-07       Impact factor: 19.112

7.  Urinary interleukin-1β levels among gynecological patients.

Authors:  Kamisha T Woolery; Mitchel S Hoffman; Joshua Kraft; Santo V Nicosia; Ambuj Kumar; Patricia A Kruk
Journal:  J Ovarian Res       Date:  2014-11-18       Impact factor: 4.234

8.  Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.

Authors:  Mette T Faber; Susanne K Kjær; Christian Dehlendorff; Jenny Chang-Claude; Klaus K Andersen; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Jennifer A Doherty; Galina Lurie; Pamela J Thompson; Michael E Carney; Marc T Goodman; Roberta B Ness; Francesmary Modugno; Robert P Edwards; Clareann H Bunker; Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Melissa C Larson; Joellen Schildkraut; Daniel W Cramer; Kathryn L Terry; Allison F Vitonis; Elisa V Bandera; Sara H Olson; Melony King; Urmila Chandran; Lambertus A Kiemeney; Leon F A G Massuger; Anne M van Altena; Sita H Vermeulen; Louise Brinton; Nicolas Wentzensen; Jolanta Lissowska; Hannah P Yang; Kirsten B Moysich; Kunle Odunsi; Karin Kasza; Oluwatosin Odunsi-Akanji; Honglin Song; Paul Pharaoh; Mitul Shah; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Rebecca Sutphen; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Celeste Leigh Pearce; Anna H Wu; Malcolm C Pike; Harvey A Risch; Allan Jensen
Journal:  Cancer Causes Control       Date:  2013-03-02       Impact factor: 2.506

Review 9.  Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management.

Authors:  Anna L Beavis; Anna Jo Bodurtha Smith; Amanda Nickles Fader
Journal:  Int J Womens Health       Date:  2016-05-23

10.  Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.

Authors:  Patrizia Vici; Laura Pizzuti; Luigi Di Lauro; Laura Conti; Chiara Mandoj; Anna Antenucci; Giovanna Digiesi; Domenico Sergi; Antonella Amodio; Paolo Marchetti; Francesca Sperati; Mario Valle; Alfredo Garofalo; Enrico Vizza; Giacomo Corrado; Cristina Vincenzoni; Federica Tomao; Ramy Kayal; Annalise Marsella; Mariantonia Carosi; Barbara Antoniani; Antonio Giordano; Marcello Maugeri-Saccà; Maddalena Barba
Journal:  J Cancer       Date:  2016-02-10       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.